Polydex Pharmaceuticals Limited (POLXF) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Polydex Pharmaceuticals Limited's investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
-0.36
Burn Risk
P/B Ratio
0.23
Strong
WeakModerateStrong
Earnings Yield
-2.75%
Yield Gap
Profitability Health
2010Return on Equity
-63.38%
Weak
WeakModerateStrong
Operating Margin
-26.23%
Weak
WeakModerateStrong
Net Profit Margin
-49.08%
Weak
WeakModerateStrong
Growth Indicators
2010Revenue Growth
-7.12%
Weak
WeakModerateStrong
Net Income Growth
-38.20%
Weak
WeakModerateStrong
EPS Growth
-38.46%
Weak
WeakModerateStrong
Efficiency & Liquidity
2010Current Ratio
1.26
Moderate
WeakModerateStrong
Quick Ratio
0.57
Weak
WeakModerateStrong
Asset Turnover
0.78x
Moderate
WeakModerateStrong
Inventory Turnover
3.86x
Weak
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
-82.37%
Weak
WeakModerateStrong
EV / Free Cash Flow
-2.94x
Strong
WeakModerateStrong
Net Debt / EBITDA
-1.52x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
1.824
Strong
WeakModerateStrong
Return on Invested Capital
-25.50%
Weak
WeakModerateStrong
Cash Conversion Cycle
95.08 days
Weak
WeakModerateStrong
Fortress screener guardrails
1/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for POLXF.
View Financial Statements